Nutex Health (NASDAQ:NUTX) Stock Rating Cut to Hold at Wall Street Zen

Key Points

• Wall Street Zen downgraded Nutex Health from “buy” to “hold.” Despite the cut, analysts overall maintain a “Moderate Buy” consensus, with four Buy ratings and one Hold rating and an average price target of $323.67.
• NUTX opened at $200.15 after a reported 4.7% decline, with a market capitalization of approximately $1.37 billion. The company’s latest quarterly EPS of $9.38 exceeded estimates of $4.95, although revenue came in slightly below expectations.
• Insider ownership remains significant at 44.68%. Director Scott Saunders recently sold 203 shares, while institutional investors own 5.32% of the company and several funds recently initiated or increased positions.

Nutex Health (NASDAQ:NUTX - Get Free Report) was downgraded by stock analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a research note issued on Saturday, Wall Street Zen reports.

A number of other analysts have also issued reports on NUTX. Zacks Research lowered Nutex Health from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, October 6th. LADENBURG THALM/SH SH initiated coverage on Nutex Health in a research note on Monday, October 26th. They issued a "buy" rating and a $336.00 price objective for the company. B. Riley Financial reissued a "buy" rating on shares of Nutex Health in a research note on Friday, September 4th. Weiss Ratings upgraded Nutex Health from a "hold (c+)" rating to a "buy (b-)" rating in a report on Tuesday, October 6th. Finally, Lake Street Capital reaffirmed a "buy" rating and set a $310.00 target price (up from $235.00) on shares of Nutex Health in a research note on Tuesday, August 11th. Four investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $323.67.

Nutex Health Stock Down 4.7%

NUTX opened at $200.15 on Friday. The company has a market cap of $1.37 billion, a PE ratio of 8.25 and a beta of 0.55. Nutex Health has a twelve month low of $83.99 and a twelve month high of $226.16. The company has a 50-day moving average price of $203.24 and a 200 day moving average price of $150.70. The company has a quick ratio of 4.96, a current ratio of 5.00 and a debt-to-equity ratio of 0.59.

Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported $9.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.95 by $4.43. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%. The company had revenue of $210.75 million for the quarter, compared to analysts' expectations of $215.03 million. Sell-side analysts expect that Nutex Health will post 26.65 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Scott Saunders sold 203 shares of the business's stock in a transaction that occurred on Friday, September 18th. The stock was sold at an average price of $214.25, for a total transaction of $43,492.75. Following the transaction, the director directly owned 400 shares in the company, valued at $85,700. The trade was a 33.67% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 44.68% of the stock is owned by company insiders.

Institutional Investors Weigh In On Nutex Health

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Kilter Group LLC acquired a new position in shares of Nutex Health during the 2nd quarter valued at about $27,000. Allworth Financial LP purchased a new stake in shares of Nutex Health in the second quarter valued at about $35,000. GK Wealth Management LLC acquired a new stake in Nutex Health during the third quarter worth about $73,000. EverSource Wealth Advisors LLC acquired a new stake in Nutex Health during the first quarter worth about $83,000. Finally, State of Alaska Department of Revenue increased its position in Nutex Health by 243.6% during the third quarter. State of Alaska Department of Revenue now owns 1,000 shares of the company's stock worth $211,000 after purchasing an additional 709 shares during the last quarter. Institutional investors and hedge funds own 5.32% of the company's stock.

Nutex Health Company Profile

Nutex Health, Inc NASDAQ: NUTX is a physician-led healthcare services company that operates an integrated network of hospitals, medical facilities and physician practices in the United States. The company focuses on providing convenient, community-based care through its micro-hospitals and other healthcare locations.

Its hospital operations generally include emergency services, inpatient care, diagnostic testing and outpatient treatment. Nutex also operates physician networks and supports primary care and specialty providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.